1. Anderson S, Meyer TW, Brenner BM. The role of hemodynamic factors in the initiation and progression of renal disease. J Urol 1985;363.
2. Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol 2000;24:4.
3. Argueso LR, Ritchey ML, Boyle ET Jr, et al. Prognosis of the solitary kidney after unilateral nephrectomy in childhood. J Urol 1992;148:747.
4. Banner MP, Pollack HM, Chatten J, et al. Multilocular renal cysts: radiologic-pathologic correlation. AJR Am J Roentgenol 1981;136:239.
5. Bardeesy N, Falkoff D, Petruzzi MJ, et al. Anaplastic Wilms’ tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 1994;7:91.
6. Beckwith JB. Macroglossia, omphalocele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects: Original Article Series 1969;5:88.
7. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumor. Results from the National Wilms Tumor Study. Cancer 1978;41:1937.
8. Reference deleted in proofs.
9. Beckwith JB. Congenital mesoblastic nephroma. When should we worry? Arch Pathol Lab Med 1986;110:98.
10. Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol 1990;10:1.
11. Reference deleted in proofs.
12. Beckwith JB. Should asymptomatic unilateral multicystic dysplastic kidneys be removed because of the future risk of neoplasia? Pediatr Nephrol 1992;6:511.
13. Beckwith JB. Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol 1993;21:158.
14. Beckwith JB. Certain conditions have an increased incidence of Wilms’ tumor. AJR Am J Roentgenol 1996;164:1294.
15. Beckwith JB, Zuppan CE, Browning NG, et al. Histological analysis of aggressiveness and responsiveness in Wilms tumor. Med Pediatr Oncol 1996;27:422.
16. Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet 1998;79:268.
17. Bennington JL, Beckwith JB. Tumors of the kidney, renal pelvis, and ureter. In: Firminger HI, ed. Atlas of tumor pathology, Second Series, Fasicle 12. Bethesda: Armed Forces Institute of Pathology, 1975.
18. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74.
18a. Blank E, Neerhout RC, Burry KA. Congenital mesoblastic nephroma and polyhydramnios. JAMA 1978;240:1504.
19. Blute ML, Kelalis PP, Offord KP, et al. Bilateral Wilms’ tumor. J Urol 1987;138:968.
20. Blute ML, Malek RS, Segura JW. Angiomyolipoma: a clinical metamorphosis and concepts for management. J Urol 1988;139:20.
21. Boccon-Gibod L, Rey A, Sandstedt B, et al. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the International Society of Paediatric Oncology (SIOP) Nephroblastoma Trial and Study 9. Med Pediatr Oncol 2000;34:183.
22. Bolande RP, Brough AJ, Izant RJ Jr. Congenital mesoblastic nephroma of infancy: a report of eight cases and the relationship to Wilms’ tumor. Pediatrics 1967;40:272.
23. Bonadio JF, Storer B, Norkool P, et al. Anaplastic Wilms’ tumor: clinical and pathological studies. J Clin Oncol 1985; 3:513.
24. Bonetta L, Kuehn SE, Huang A, et al. Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts. Science 1990;250:994.
25. Bonnin JM, Rubenstein IJ, Palmer NF, et al. The association of embryonal tumors originating in the kidney and the brain. Cancer 1984;54:2137.
26. Borden TA. Wilms tumor and pulmonary embolism. Soc Pediatr Urol Newsletter 1992; p27.
27. Borer JG, Kaefer M, Barnewolt CE, et al. Renal findings on radiological follow-up of patients with Beckwith-Wiedemann syndrome. J Urol 1999;161:235.
28. Reference deleted in proofs.
29. Breslow NB, Churchill G, Beckwith JB, et al. Prognosis for Wilms’ tumor patients with nonmetatastic disease at diagnosis—results of the Second National Wilms’ Tumor Study. J Clin Oncol 1985;3:521.
30. Breslow NE, Norkool PA, Olshan A, et al. Second malignant neoplasm in survivors of Wilms’ tumor: a report from the National Wilms’ Tumor Study. J Natl Cancer Inst 1988; 80:592.
31. Breslow N, Olshan A, Beckwith JB, et al. Epidemiology of Wilms’ tumor. Med Pediatr Oncol 1993;21:172.
32. Breslow N, Olshan A, Beckwith JB, et al. Ethnic variation in the incidence, diagnosis, prognosis and follow-up of children with Wilms’ tumor. J Natl Cancer Inst 1994;86:49.
33. Breslow NE, Partin AW, Lee BR, et al. Nuclear morphometry and prognosis in favorable histology Wilms tumor: a prospective reevaluation. J Clin Oncol 1999;17:2123.
34. Breslow NE, Takashima J, Ritchey ML, et al. Renal failure in the Denys-Drash and Wilms tumor aniridia syndromes. Cancer Res 2000;60:4030.
35. Broecker B. Renal cell carcinoma in children. Urology 1991; 38:54.
36. Burger D, Moorman-Voestermans CGM, Mildenberger H, et al. The advantages of preoperative therapy in Wilms’ tumor: a summarized report on clinical trials conducted by the International Society of Paediatric Oncology (SIOP). Z Kinderchir 1985;40:170.
37. Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 1990;60:509.
38. Castellanos RD, Aron BS, Evans AT. Renal adenocarcinoma in children: incidence, therapy and prognosis. J Urol 1974; 111:534.
39. Choyke PL, Siegel MJ, Craft AW, et al. Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 1999; 32:196.
40. Clericuzio CL. Clinical phenotypes and Wilms tumor. Med Pediatr Oncol 1993;21:182.
41. Cohen MD. Staging of Wilms’ tumor. Clin Radiol 1993; 47:77.
42. Cooper CS, Jaffe WI, Huff DS, et al. The role of renal salvage procedures for bilateral Wilms tumor: a 15-year review. J Urol 2000;163:265.
43. Coppes MJ, deKraker J, vanKijken PJ, et al. Bilateral Wilms’ tumor: long-term survival and some epidemiological features. J Clin Oncol 1989;7:310.
44. Coppes MJ, Liefers GJ, Higuchi M, et al. Inherited WT1 mutations in Denys-Drash syndrome. Cancer Res 1992;52:6125.
45. Coppes MJ, Huff V, Pelletier J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J Pediatr 1993;123:673.
46. Coppes MJ. Serum biological markers and paraneoplastic syndromes in Wilms tumor. Med Pediatr Oncol 1993;21:213.
47. Coppes MJ, Haber DA, Grundy P. Genetic events in the development of Wilms tumor: current concepts. N Engl J Med 1994;331:586.
48. Coppes MJ, Egeler RM. Genetics of Wilms’ tumor. Semin Urol Oncol 1999;17:2.
49. Coppes MJ, Arnold M, Beckwith JB, et al. Factors affecting the risk of contralateral Wilms tumor development. Cancer 1999;85:1616.
50. Cozzi F, Schiavetti A, Clerico A, et al. Tumor enucleation in unilateral Wilms’ tumor: a pilot study. Med Pediatr Oncol 1995;25:313.
51. D’Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms’ tumor: results of the National Wilms’ Tumor Study. Cancer 1976;38:633.
52. D’Angio GJ, Evans A, Breslow N, et al. The treatment of Wilms’ tumor: results of the Second National Wilms’ Tumor Study. Cancer 1981;47:2302.
53. D’Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms’ tumor: results of the Third National Wilms’ Tumor Study. Cancer 1989;64:349.
54. D’Angio GJ, Rosenberg H, Sharples K, et al. Position paper. Imaging methods for primary renal tumors of childhood: cost versus benefits. Med Pediatr Oncol 1993;21:205.
55. Debaun MR, Tucker MA. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry. J Pediatr 1998;132:377.
56. Debaun MR, Siegel MJ, Choyke PL. Nephromegaly in infancy and early childhood: a risk factor for Wilms tumor in Beckwith-Wiedemann syndrome. J Pediatr 1998;132:401.
57. Reference deleted in proofs.
58. Dehner LP, Leestma JE, Price EB Jr. Renal cell carcinoma in children: a clinicopathologic study of 15 cases and review of the literature. J Pediatr 1970;76:358.
59. Diller L, Ghhremani M, Morgan J, et al. Constitutional WT1 mutations in Wilms tumor patients. J Clin Oncol 1998;16:3634.
60. Reference deleted in proofs.
61. Ditchfield MR, DeCampo JF, Waters KD, et al. Wilms’ tumor: a rational use of preoperative imaging. Med Pediatr Oncol 1995;24:93.
62. Dome JS, Chung S, Bergemann T, et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms tumor. Cancer Res 1999;59:4301.
63. Drash A, Sherman F, Hartmann WH, et al. A syndrome of pseudohermaphroditism, Wilms tumor, hypertension and degenerative renal disease. J Pediatr 1970;76:585.
64. Reference deleted in proofs.
65. Eble JN, Bonsib SM. Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diag Pathol 1998;15:2.
66. Evans AE, Norkool P, Evans I, et al. Late effects of treatment for Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. Cancer 1991;67:331.
67. Reference deleted in proofs.
68. Faria P, Beckwith JB. A new definition of focal anaplasia (FA) in Wilms tumor identifies cases with good outcome. A report from the National Wilms Tumor Study [Abstract]. Mod Pathol 1993;6:3p.
69. Reference deleted in proofs.
70. Gilladoga AC, Manuel C, Tan CT, et al. The cardiotoxicity of adriamycin and daunomycin in children. Cancer 1976;37:1070.
71. Glass RBJ, Davidson AJ, Fernbach SK. Clear cell sarcoma of the kidney: CT, sonographic and pathologic correlation. Radiology 1991;180:715.
72. Gleason PE, Kramer SA. Genitourinary polyps in children. Urology 1994;44:106.
73. Godzinski J, Tournade MF, deKraker J, et al. Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and study “SIOP-9”. International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. Eur J Pediatr Surg 1998;8:83.
74. Reference deleted in proofs.
75. Reference deleted in proofs.
76. Gormley TS, Skoog SJ, Jones RV, et al. Cellular congenital mesoblastic nephroma: What are the options? J Urol 1989; 142:479.
77. Reference deleted in proofs.
78. Green DM, Fine NE, Li FP. Offspring of patients treated for unilateral Wilms’ tumor in childhood. Cancer 1982;49:2285.
79. Green DM, D’Angio GJ, Kelalis PP, et al. The risks associated with prenephrectomy chemotherapy for unilateral Wilms’ tumor patients. Dial Pediatr Urol 1992;15:7.
80. Green DM, Breslow NE, Beckwith JB, et al. Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms’ tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol 1993;21:188.
81. Green DM, Breslow NE, Beckwith JB, et al. Treatment outcomes in patients less than two years of age with small, stage I/favorable histology Wilms tumors. A report from the National Wilms Tumor Study. J Clin Oncol 1993;11:91.
82. Green DM, Breslow NE, D’Angio GJ. The treatment of children with unilateral Wilms tumor. J Clin Oncol 1993;11:1009.
83. Green DM, Beckwith JB, Breslow NB, et al. The treatment of children with Stage II-IV anaplastic Wilms tumor. A report from the National Wilms Tumor Study. J Clin Oncol 1994;12:2126.
84. Green DM, Beckwith JB, Weeks DA, et al. The relationship between microsubstaging variables, tumor weight and age at diagnosis of children with stage I/favorable histology Wilms tumor. A report from the National Wilms Tumor Study. Cancer 1994;74:1817.
85. Green DM, Breslow NE, Evan I, et al. Effect of dose intensity of chemotherapy on the hematological toxicity of the treatment of Wilms tumor. A report from the National Wilms Tumor Study. Am J Pediatr Hematol Oncol 1994;16:207.
86. Green DM, Breslow NE, Beckwith JB, et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. J Clin Oncol 1998;16:237.
87. Green DM Breslow NE, Beckwith JBB, et al. Effect of duration of treatment on treatment outcomes and cost of treatment for Wilms’ tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 1998;16:3744.
88. Green D, Breslow N, Ritchey M, et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms tumor. A report from the National Wilms Tumor Study Group. Proc ASCO 2000;19:582A.
89. Green DM, Nan B, Grigoriev YA, et al. Congestive failure after treatment for Wilms tumor. A report from the National Wilms Tumor Study Group. Med Pediatr Oncol 2001 (in press).
90. Grundy P, Breslow N, Green DM, et al. Prognostic factors for children with recurrent Wilms’ tumor: results from the Second and Third National Wilms Tumor Study. J Clin Oncol 1989;7:638.
91. Grundy PE, Telzerow PE, Breslow N, et al. Loss of heterozygosity for chromosomes 16q and 1p in Wilms tumor predicts an adverse outcome. Cancer Res 1994;54:2331.
92. Grundy PE, Telzerow PE, Moksness J, et al. Clinicopathologic correlates of loss of heterozygosity in Wilms tumor: a preliminary analysis. Med Pediatr Oncol 1996;27:429.
93. Harris CC. The carcinogenicity of anticancer drugs: a hazard in man. Cancer 1976;37:1014.
94. Hartman D, Davis C, Madewell J, et al. Primary malignant tumors in the second decade of life: Wilms tumor versus renal cell carcinoma. J Urol 1982;127:888.
95. Heidelberger KP, Ritchey ML, Dauser RC, et al. Congenital mesoblastic nephroma metastatic to the brain. Cancer 1993;72:2499.
96. Reference deleted in proofs.
97. Hittner HM, Riccardi VM, Ferrell RE, et al. Genetic heterogeneity of aniridia: negative linkage data. Metab Pediatr Syst Ophthalmol 1980;4:179.
98. Horwitz J, Ritchey ML, Moksness J, et al. Renal salvage procedures in patients with synchronous bilateral Wilms tumors: a report of the NWTSG. J Pediatr Surg 1996;31:1020.
99. Howell CJ, Othersen HB, Kiviat NE, et al. Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms’ Tumor Study. J Pediatr Surg 1982; 17:826.
100. Hudson HC, Kramer SA, Tatum AH, et al. Transitional cell carcinoma of renal pelvis: rare occurrence in young male. Urology 1981;18:284.
101. Huff V, Villalba F, Riccardi VM, et al. Alteration of the WT1 gene in patients with Wilms’ tumor and genitourinary anomalies [Abstract]. Am J Hum Genet 1991;49:44.
102. Huff V. Inheritance and functionality of Wilms tumor genes. The Cancer Bulletin 1994;46:255.
103. Reference deleted in proofs.
104. Johnson DE, Ayala AG, Medellin H, et al. Multilocular renal cystic disease in children. J Urol 1973;109:101.
105. Joshi VV, Kasznica J, Walters TR. Atypical mesoblastic nephroma. Pathologic characterization of a potentially aggressive variant of conventional congenital mesoblastic nephroma. Arch Pathol Lab Med 1986;110:100.
106. Joshi VV, Beckwith JB. Multilocular cyst of the kidney (cystic nephroma) and cystic, partially differentiated nephroblastoma. Terminology and criteria for diagnosis. Cancer 1989; 64:466.
107. Karth J, Ferrer F, Hanrahan C, et al. Co-expression of hypoxia inducible factor 1 alpha and vascular endothelial growth factor in human Wilms’ tumor. J Urol 2000;163:137.
108. Kayton ML, Rowe DH, O’Toole KM, et al. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms tumor. J Pediatr Surg 1999;34:743.
109. Kinsella TJ, Trivette G, Rowland J, et al. Long-term follow-up of testicular function following radiation for early-stage Hodgkin’s disease. J Clin Oncol 1989;7:718.
110. Knudson AG and Strong LC. Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst 1972; 48:313.
111. Koo AS, Koyle MA, Hurwitz RS, et al. The necessity of contralateral surgical exploration in Wilms’ tumor with modern noninvasive imaging technique: a reassessment. J Urol 1990;144:416.
112. Koufos A, Hansen MF, Lampkin BC, et al. Loss of alleles at loci on human chromosome 11 during genesis of Wilms’ tumor. Nature 1984;309:170.
113. Koufos A, Grundy P, Morgan K, et al. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 1989;44:711.
114. Kovalic JJ, Thomas PRM, Beckwith JB, et al. Hepatocellular carcinoma as second malignant neoplasms in successfully treated Wilms’ tumor patients. Cancer 1991;67:342.
115. Kumar R, Fitzgerald R, Breatnach F. Conservative surgical management of bilateral Wilms tumor: results of the United Kingdom Children’s Cancer Study Group. J Urol 1998;160:1450.
116. Larsen E, Perez-Atayde A, Green DM, et al. Surgery only for the treatment of patients with stage I (Cassady) Wilms’ tumor. Cancer 1990;66:264.
117. Lee W, Kim TS, Chung JW, et al. Renal angiomyolipoma: embolotherapy with a mixture of alcohol and iodized oil. J Vasc Interv Radiol 1998;9:255.
118. Lemerle J, Voute PA, Tournade MF, et al. Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms’ tumor: preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (SIOP). Cancer 1976; 38:647.
119. Lemerle J, Voute PA, Tournade MF, et al. Effectiveness of preoperative chemotherapy in Wilms’ tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol 1983;1:604.
120. Levin NP, Damjanov I, Depillis VJ. Mesoblastic nephroma in an adult patient. Recurrence 21 years after removal of the primary. Cancer 1982;49:573.
121. Li FP, Yan JC, Sallan S, et al. Second neoplasms after Wilms tumor in childhood. J Natl Cancer Inst 1983;71:1205.
122. Li FP, Gimbrere K, Gelber RD, et al. Outcome of pregnancy in survivors of Wilms tumor. JAMA 1987;257:216.
123. Lin RY, Argenta PA, Sullivan KM, et al. Urinary hyaluronic acid is a Wilms tumor marker. J Pediatr Surg 1995;30:304.
124. Lin RY, Argenta PA, Sullivan KM, et al. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms tumor patients. Clin Cancer Res 1995;1:327.
125. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233.
126. Maw MA, Grundy PE, Millow LJ, et al. A third Wilms’ tumor locus on chromosome 16q. Cancer Res 1992;52:3094.
127. McLorie GA, McKenna PH, Greenburg M, et al. Reduction in tumor burden allowing partial nephrectomy following preoperative chemotherapy in biopsy proved Wilms’ tumor. J Urol 1991;146:509.
128. Mesrobian H-G, Kelalis PP, Hrabovsky E, et al. Wilms’ tumor in horseshoe kidneys. J Urol 1985;133:1002.
129. Miller RW, Fraumeni JF, Manning MD. Association of Wilms tumor with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 1964;270:922.
130. Montgomery BT, Kelalis PP, Blute ML, et al. Extended follow-up of bilateral Wilms’ tumor: Results of the National Wilms Tumor Study. J Urol 1991;146:514.
131. Moorman-Voestermans, C Aronson D, Staalman CR, et al. Is partial nephrectomy appropriate treatment for unilateral Wilms’ tumor? J Pediatr Surg 1998;33:165.
132. Nakayama DK, deLorimier AA, O’Neill JA Jr, et al. Intracardiac extension of Wilms’ tumor: a report of the National Wilms’ Tumor Study. Ann Surg 1986;204:693.
133. Reference deleted in proofs.
134. Reference deleted in proofs.
135. Neri G, Gurrieri F, Zanni G, et al. Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am J Med Genet 1998;79:279.
136. Neville H, Ritchey M, Shamberger R, et al. The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG). Pediatrics 1999;104:772.
137. Ng YY, Hall-Craggs MA, Dicks-Mireaux C, et al. Wilms’ tumour: pre- and post-chemotherapy CT appearances. Clin Radiol 1991;43:255.
138. Noe HN, Marshall JH, Edwards. Nodular renal blastema in the multicystic kidney. J Urol 1989;142:486.
139. Oberholzer HF, Falkson G, DeJager LC. Successful management of inferior vena cava and right atrial nephroblastoma tumor thrombus with preoperative chemotherapy. Med Pediatr Oncol 1992;20:61.
140. Ohmichi M, Tasaka K, Sugita N, et al. Hydramnios associated with congenital mesoblastic nephroma: a case report. Obstet Gynecol 1989;74:469.
141. Othersen HB, Jr, DeLorimer A, Hrabovsky E, et al. Surgical evaluation of lymph node metastases in Wilms’ tumor. J Pediatr Surg 1990;25:3:1.
142. Partin AW, Walsh AC, Epstein JI, et al. Nuclear morphometry as a predictor of response to therapy in Wilms’ tumor: a preliminary report. J Urol 1990;144:1222.
143. Partin AW, Gearhart JP, Leonard MP, et al. The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review. Med Pediatr Oncol 1993;21:222.
144. Pelletier J, Bruening W, Kashtan CE, et al. Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67:437.
145. Penn I. Renal transplantation for Wilms’ tumor: report of 20 cases. J Urol 1979;122:793.
146. Perlman M, Levin M, Wittels B. Syndrome of fetal gigantism, renal hamartomas, and nephroblastomatosis with Wilms’ tumor. Cancer 1975;35:1212.
147. Pochedly C, Suwansirikul S, Penzer P. Renal cell carcinoma with extrarenal manifestations in a 10 month child. Am J Dis Child 1971;121:528.
148. Povey S Burley M, Attwood J, et al. Two loci for tuberous sclerosis: one on 9q34 and one on 16p13. Ann Hum Genet 1994;58:107.
149. Priestly JT, Schulte TL. The treatment of Wilms’ tumor. Urology 1942;47:7.
150. Pritchard-Jones K, Fleming S, et al. The candidate Wilms’ tumour gene is involved in genitourinary development. Nature 1990;346:194.
151. Rainwater LM, Hosaka Y, Farrow GM, et al. Wilms tumors: relationship of nuclear deoxyribonucleic acid ploidy to patient survival. J Urol 1987;138:974.
152. Raney RB, Jr, Palmer N, Sutow WW, et al. Renal cell carcinoma in children. Med Pediatr Oncol 1983;11:91.
153. Reeve AE, Sih SA, Raizis AM, et al. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms’ tumor cells. Molec Cell Biol 1989;44:711.
154. Riccardi VM, Sujansky E, Smith AC, et al. Chromosomal imbalance in the aniridia-Wilms’ tumor association: 11p interstitial deletion. Pediatrics 1978;61:604.
155. Ritchey ML, Kelalis PP, Breslow N, et al. Intracaval and atrial involvement with nephroblastoma: Review of National Wilms’ Tumor Study-3. J Urol 1988;140:1113.
156. Ritchey ML, Othersen HB, Jr, deLorimier AA, et al. Renal vein involvement with nephroblastoma: a report of National Wilms’ Tumor Study-3. Eur Urol 1990;17:139.
157. Ritchey ML, Kelalis PP, Breslow N, et al. Surgical complications following nephrectomy for Wilms’ tumor: a report of National Wilms’ Tumor Study-3. Surg Gynecol Obstet 1992;175:507.
158. Ritchey ML, Lally KP, Haase GM, et al. Superior mesenteric artery injury during nephrectomy for Wilms’ Tumor. J Pediatr Surg 1992;27:612.
159. Ritchey ML, Kelalis PP, Haase GM, et al. Preoperative therapy for intracaval and atrial extension of Wilms’ tumor. Cancer 1993;71:41.
160. Ritchey ML, Kelalis P, Breslow N, et al. Small bowel obstruction following nephrectomy for Wilms’ tumor. Ann Surg 1993;218:654.
161. Ritchey ML, Pringle K, Breslow N, et al. Management and outcome of inoperable Wilms tumor. A report of National Wilms’ Tumor Study. Ann Surg 1994;220:683.
162. Ritchey ML, Green DM, Breslow NE, et al. Accuracy of current imaging modalities in the diagnosis of synchronous bilateral Wilms tumor. Cancer 1995;75:600.
163. Ritchey ML, Coppes M. The management of synchronous bilateral Wilms tumor. Hematol Oncol Clin North Am 1995;9:1303.
164. Ritchey ML, Green DM, Thomas P, et al. Renal failure in Wilms tumor patients: a report of the NWTSG. Med Pediatr Oncol 1996;26:75.
165. Ritchey ML, Shamberger RC, Haase G, et al. Surgical complications after nephrectomy for Wilms tumor: report from the National Wilms Tumor Study Group. Pediatrics 1999; 104:816.
166. Robitaille P, Mongeau JG, Lortie L, et al. Long-term follow-up of patients who underwent nephrectomy in childhood. Lancet 1985;1:1297.
167. Rowe DH, Huang J, Kayton ML, et al. Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms tumor. J Pediatr Surg 2000;35:30.
168. Rudin C, Pritchard J, Fernando ON, et al. Renal transplantation in the management of bilateral Wilms’ tumour (BWT) and of Denys-Drash syndrome (DDS). Nephrol Dial Transplant 1998;13(6):1506.
169. Schmidt D, Beckwith JB. Histopathology of childhood renal tumors. Hematol Oncol Clin North Am 1995;9:1179.
170. Shamberger RC, Guthrie KA, Ritchey ML, et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg 1999;229:292.
171. Shaul DB, Srikanth MM, Ortega JA et al. Treatment of bilateral Wilms’ tumor: comparison of initial biopsy and chemotherapy to initial surgical resection in the preservation of renal mass and function. J Pediatr Surg 1992;27:1009.
172. Shulkin BL, Chang E, Strouse PJ, et al. PET FDG studies of Wilms tumors. J Pediatr Hematol Oncol 1997;19:334.
173. Shurin SB, Gauderer MWL, Dahms BB, et al. Fatal intraoperative pulmonary embolization of Wilms tumor. J Pediatr 1982;101:559.
174. Reference deleted in proofs.
175. Snyder HM III, Lack EE, Chetty-Baktovizian A, et al. Congenital mesoblastic nephroma. Relationship to other renal tumors of infancy. J Urol 1981;126:513.
176. Stay EJ, Vawter G. The relationship between nephroblastoma and neurofibromatosis (von Recklinghausen’s disease). Cancer 1977;39:2550.
177. Steinherz LJ, Steinherz PG, Tan CTC, et al. Cardiac toxicity 4 to 20 years after anthracycline therapy. JAMA 1991;266:1672.
178. Stillman RJ, Schinfeld JS, Schiff I, et al. Ovarian failure in long term survivors of childhood malignancy. Am J Obstet Gynecol 1987;139:62.
179. Tank ES, Kay R. Neoplasms associated with hemihypertrophy, Beckwith-Wiedemann syndrome and aniridia. J Urol 1980;124:266.
180. Tank ES, Melvin T. The association of Wilms’ tumor with nephrologic disease. J Pediatr Surg 1990;25:724.
181. Tomlinson GE, Argyle JC, Velasco S, et al. Molecular characterization of congenital mesoblastic nephroma and its distinction from Wilms tumor. Cancer 1992;70:2358.
182. Tournade MF, Com-Nougue C, Voute PA, et al. Results of the sixth International Society of Pediatric Oncology Wilms’ tumor trial and study: a risk-adapted therapeutic approach in Wilms’ tumor. J Clin Oncol 1993;11:1014.
183. Tournade MF, deKraker J, Lemerle J, et al. Preoperative chemotherapy of patients over 6 months of age with a nephroblastoma. A report of the SIOP Wilms’ tumor (WT) trials and studies. Med Pediatr Oncol 1994;23:171.
184. Voute PA, Van Der Meer J, Staugaard-Kloosterziel W. Plasma renin activity in Wilms’ tumour. Acta Endocrinologica 1971; 67:197.
185. Vujanic GM, Harms D, Sandstedt B, et al. New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatr Oncol 1999;32:317.
186. Weeks DA, Beckwith JB. Relapse-associated variables in stage I, favorable histology Wilms’ tumor. Cancer 1987;60:1204.
187. Weeks DA, Beckwith JB, Mierau G, et al. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms’ Tumor Study Pathology Center. Am J Surg Pathol 1989;13:439.
188. Weese DL, Applebaum H, Taber P. Mapping intravascular extension of Wilms’ tumor with magnetic resonance imaging. J Pediatr Surg 1991;26:64.
189. White KS, Grossman H. Wilms’ and associated renal tumors of childhood. Pediatr Radiol 1991;21:81.
190. Wiedemann H. Tumors and hemihypertrophy associated with the Wiedemann-Beckwith syndrome. Eur J Pediatr 1983;141:129.
191. Zakowski MF, Edwards RH, McDonough ET. Wilms’ tumor presenting as sudden death due to tumor embolism. Arch Pathol Lab Med 1990;114:605.
192. Zantiga AR, Coppes MJ. Max Wilms (1867-1918): The man behind the eponym. Med Pediatr Oncol 1992;20:515.
193. Zuppan CW, Beckwith JB, Weeks DA, et al. The effect of preoperative therapy on the histologic features of Wilms’ tumor. An analysis of cases from the Third National Wilms’ Tumor Study. Cancer 1991;68:385.